Timmerman Iris, Robert Marie-Claude, Vergneau-Grosset Claire, Juette Tristan, Benito Javier, Garbin Marta, Zamani-Roudbaraki Mostafa, Moradi Mona, Goodarzi Hamid, Boutopoulos Christos, Benoit-Biancamano Marie-Odile, Griffith May, Vanore Maria
Faculty of Veterinary Medicine, Université de Montréal, 3200 Rue Sicotte, Saint-Hyacinthe, QC J2S 2M2, Canada.
Department of Ophthalmology, University of Montreal and Maisonneuve-Rosemont Hospital Research Centre, 5690 Boul. Rosemont, Pavillon Claudine D'Amours, Montreal, QC H1T 2H2, Canada.
Vet Sci. 2025 Aug 21;12(8):785. doi: 10.3390/vetsci12080785.
Pro-regenerative corneal implants are being developed to improve corneal healing for companion animals in clinical practice. This pilot study evaluated early corneal tissue and nerve regeneration using biosynthetic collagen-analog hydrogels (CAH) in liquid and solid forms. Their efficacy was compared to each other and to allografts on nine white New Zealand rabbits, divided in three groups of three. Each rabbit cornea underwent keratectomy followed by grafting with either a control allograft cornea, liquid injectable, or solid CAH implant. Corneal healing was assessed over 16 weeks using clinical exams, esthesiometry, in vivo confocal microscopy, and optical coherence tomography. One rabbit per group was euthanized at 3, 10, and 16 weeks for histopathological analysis. Both liquid and solid implants enabled corneal re-epithelialization and regeneration of stromal tissue and corneal nerves. Esthesiometric values indicated faster nerve regeneration in rabbits grafted with biosynthetic implants compared to allografts ( < 0.005). By 16 weeks, regenerated neocorneas achieved transparency comparable to allografts. Solid and liquid CAH implants supported complete corneal tissue and nerve regeneration in the studied rabbits. These results suggest that with further research and development, the current gold standard for corneal transplantation could be replaced by high-performing, easily produced biosynthetic alternatives.
正在研发促进再生的角膜植入物,以改善临床实践中伴侣动物的角膜愈合。这项初步研究评估了使用液体和固体形式的生物合成胶原模拟水凝胶(CAH)进行早期角膜组织和神经再生的情况。在九只白色新西兰兔身上,将它们的疗效相互比较,并与同种异体移植进行比较,这些兔子被分成三组,每组三只。每只兔角膜均接受角膜切除术,然后用对照同种异体移植角膜、液体可注射或固体CAH植入物进行移植。使用临床检查、感觉测量、体内共聚焦显微镜和光学相干断层扫描在16周内评估角膜愈合情况。每组在第3、10和16周处死一只兔子进行组织病理学分析。液体和固体植入物均能实现角膜上皮再形成以及基质组织和角膜神经的再生。感觉测量值表明,与同种异体移植相比,接受生物合成植入物移植的兔子神经再生更快(<0.005)。到16周时,再生的新角膜达到了与同种异体移植相当的透明度。固体和液体CAH植入物在研究的兔子中支持了完整的角膜组织和神经再生。这些结果表明,随着进一步的研发,目前角膜移植的金标准可能会被高性能、易于生产的生物合成替代品所取代。